831 related articles for article (PubMed ID: 27066891)
1. Next generation sequencing: implications in personalized medicine and pharmacogenomics.
Rabbani B; Nakaoka H; Akhondzadeh S; Tekin M; Mahdieh N
Mol Biosyst; 2016 May; 12(6):1818-30. PubMed ID: 27066891
[TBL] [Abstract][Full Text] [Related]
2. Clinical pharmacogenomics testing in the era of next generation sequencing: challenges and opportunities for precision medicine.
Ji Y; Si Y; McMillin GA; Lyon E
Expert Rev Mol Diagn; 2018 May; 18(5):411-421. PubMed ID: 29634383
[TBL] [Abstract][Full Text] [Related]
3. Next generation sequencing in cancer: opportunities and challenges for precision cancer medicine.
Paolillo C; Londin E; Fortina P
Scand J Clin Lab Invest Suppl; 2016; 245():S84-91. PubMed ID: 27542004
[TBL] [Abstract][Full Text] [Related]
4. Next Generation Sequencing (NGS): A Revolutionary Technology in Pharmacogenomics and Personalized Medicine in Cancer.
Morganti S; Tarantino P; Ferraro E; D'Amico P; Duso BA; Curigliano G
Adv Exp Med Biol; 2019; 1168():9-30. PubMed ID: 31713162
[TBL] [Abstract][Full Text] [Related]
5. Gene and Variant Annotation for Mendelian Disorders in the Era of Advanced Sequencing Technologies.
Chakravorty S; Hegde M
Annu Rev Genomics Hum Genet; 2017 Aug; 18():229-256. PubMed ID: 28415856
[TBL] [Abstract][Full Text] [Related]
6. Controversy and debate on clinical genomics sequencing-paper 1: genomics is not exceptional: rigorous evaluations are necessary for clinical applications of genomic sequencing.
Wilson BJ; Miller FA; Rousseau F
J Clin Epidemiol; 2017 Dec; 92():4-6. PubMed ID: 28870871
[TBL] [Abstract][Full Text] [Related]
7. Systematic pharmacogenomics analysis of a Malay whole genome: proof of concept for personalized medicine.
Salleh MZ; Teh LK; Lee LS; Ismet RI; Patowary A; Joshi K; Pasha A; Ahmed AZ; Janor RM; Hamzah AS; Adam A; Yusoff K; Hoh BP; Hatta FH; Ismail MI; Scaria V; Sivasubbu S
PLoS One; 2013; 8(8):e71554. PubMed ID: 24009664
[TBL] [Abstract][Full Text] [Related]
8. Towards population-specific pharmacogenomics in the era of next-generation sequencing.
Ji X; Ning B; Liu J; Roberts R; Lesko L; Tong W; Liu Z; Shi T
Drug Discov Today; 2021 Aug; 26(8):1776-1783. PubMed ID: 33892143
[TBL] [Abstract][Full Text] [Related]
9. Opportunities and challenges of whole-genome and -exome sequencing.
Petersen BS; Fredrich B; Hoeppner MP; Ellinghaus D; Franke A
BMC Genet; 2017 Feb; 18(1):14. PubMed ID: 28193154
[TBL] [Abstract][Full Text] [Related]
10. Significance of functional disease-causal/susceptible variants identified by whole-genome analyses for the understanding of human diseases.
Hitomi Y; Tokunaga K
Proc Jpn Acad Ser B Phys Biol Sci; 2017; 93(9):657-676. PubMed ID: 29129848
[TBL] [Abstract][Full Text] [Related]
11. Choice of next-generation sequencing pipelines.
Del Chierico F; Ancora M; Marcacci M; Cammà C; Putignani L; Conti S
Methods Mol Biol; 2015; 1231():31-47. PubMed ID: 25343857
[TBL] [Abstract][Full Text] [Related]
12. The use of PanDrugs to prioritize anticancer drug treatments in a case of T-ALL based on individual genomic data.
Fernández-Navarro P; López-Nieva P; Piñeiro-Yañez E; Carreño-Tarragona G; Martinez-López J; Sánchez Pérez R; Aroca Á; Al-Shahrour F; Cobos-Fernández MÁ; Fernández-Piqueras J
BMC Cancer; 2019 Oct; 19(1):1005. PubMed ID: 31655559
[TBL] [Abstract][Full Text] [Related]
13. Next-Generation Sequencing to Study the DNA Interaction.
Kathiresan N; Ramachandran S; Kulanthaivel L
Methods Mol Biol; 2024; 2719():249-264. PubMed ID: 37803122
[TBL] [Abstract][Full Text] [Related]
14. Genomic medicine and risk prediction across the disease spectrum.
Kotze MJ; Lückhoff HK; Peeters AV; Baatjes K; Schoeman M; van der Merwe L; Grant KA; Fisher LR; van der Merwe N; Pretorius J; van Velden DP; Myburgh EJ; Pienaar FM; van Rensburg SJ; Yako YY; September AV; Moremi KE; Cronje FJ; Tiffin N; Bouwens CS; Bezuidenhout J; Apffelstaedt JP; Hough FS; Erasmus RT; Schneider JW
Crit Rev Clin Lab Sci; 2015; 52(3):120-37. PubMed ID: 25597499
[TBL] [Abstract][Full Text] [Related]
15. Opportunities and technical challenges in next-generation sequencing for diagnosis of rare pediatric diseases.
Bacchelli C; Williams HJ
Expert Rev Mol Diagn; 2016 Oct; 16(10):1073-1082. PubMed ID: 27560481
[TBL] [Abstract][Full Text] [Related]
16. NGS for Sequence Variants.
Teng S
Adv Exp Med Biol; 2016; 939():1-20. PubMed ID: 27807741
[TBL] [Abstract][Full Text] [Related]
17. [The application of next generation sequencing on epigenetic study].
Shen S; Qu Y; Zhang J
Yi Chuan; 2014 Mar; 36(3):256-75. PubMed ID: 24846966
[TBL] [Abstract][Full Text] [Related]
18. Proteogenomics: From next-generation sequencing (NGS) and mass spectrometry-based proteomics to precision medicine.
Ang MY; Low TY; Lee PY; Wan Mohamad Nazarie WF; Guryev V; Jamal R
Clin Chim Acta; 2019 Nov; 498():38-46. PubMed ID: 31421119
[TBL] [Abstract][Full Text] [Related]
19. An Overview of DNA Analytical Methods.
Arboleda VA; Xian RR
Methods Mol Biol; 2019; 1897():385-402. PubMed ID: 30539459
[TBL] [Abstract][Full Text] [Related]
20. Challenges Related to the Use of Next-Generation Sequencing for the Optimization of Drug Therapy.
Zhou Y; Lauschke VM
Handb Exp Pharmacol; 2023; 280():237-260. PubMed ID: 35792943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
